Turtle Creek Wealth Advisors LLC Buys 1,647 Shares of Cigna Group $CI

Key Points

• Turtle Creek Wealth Advisors LLC increased its ownership in Cigna Group by 9.7%, acquiring an additional 1,647 shares during the 2nd quarter, bringing its total holdings to 18,540 shares valued at approximately $6.13 million.
• Insider transactions included the sale of 28,526 shares by Nicole S. Jones, indicating a significant 52.66% decrease in her position, while another insider, Brian C. Evanko, sold 5,368 shares, representing a 9.49% decrease.
• Cigna Group's stock recently reported earnings of $7.20 EPS, exceeding analyst expectations, with a quarterly revenue of $67.13 billion, marking an 11% increase year-over-year.

Turtle Creek Wealth Advisors LLC lifted its stake in Cigna Group (NYSE:CI - Free Report) by 9.7% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,540 shares of the health services provider's stock after buying an additional 1,647 shares during the quarter. Turtle Creek Wealth Advisors LLC's holdings in Cigna Group were worth $6,129,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Flaharty Asset Management LLC purchased a new position in Cigna Group in the 1st quarter worth approximately $28,000. 1248 Management LLC purchased a new position in Cigna Group in the 1st quarter worth approximately $29,000. Activest Wealth Management lifted its holdings in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock worth $30,000 after purchasing an additional 72 shares in the last quarter. Retirement Wealth Solutions LLC lifted its holdings in Cigna Group by 74.1% in the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider's stock worth $33,000 after purchasing an additional 43 shares in the last quarter. Finally, Saudi Central Bank purchased a new position in Cigna Group in the 1st quarter worth approximately $36,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the business's stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider owned 51,182 shares of the company's stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by insiders.

Cigna Group Price Performance

Shares of Cigna Group stock opened at $294.79 on Thursday. The stock has a market cap of $78.69 billion, a price-to-earnings ratio of 16.09, a price-to-earnings-growth ratio of 0.89 and a beta of 0.45. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The stock has a 50 day moving average price of $296.36 and a 200-day moving average price of $308.77. Cigna Group has a one year low of $256.89 and a one year high of $358.88.

Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to analysts' expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company's quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were issued a $1.51 dividend. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group's payout ratio is 32.97%.

Analysts Set New Price Targets

A number of research firms recently commented on CI. Wells Fargo & Company boosted their price target on Cigna Group from $340.00 to $354.00 and gave the stock an "equal weight" rating in a report on Tuesday, October 7th. Wolfe Research reduced their price objective on Cigna Group from $345.00 to $325.00 and set an "outperform" rating on the stock in a research note on Wednesday. Robert W. Baird set a $372.00 price objective on Cigna Group in a research note on Thursday, August 14th. TD Cowen raised Cigna Group to a "strong-buy" rating in a research note on Monday, June 23rd. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $365.00 price objective on shares of Cigna Group in a research note on Tuesday, August 26th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $369.89.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.